LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 25.85%7.31B | 15.51%6.13B | 11.74%5.66B | 2.87%22.53B | 3.36%6.35B | 0.20%5.81B | 8.05%5.3B | 0.31%5.07B | 12.98%21.9B | 6.26%6.14B |
Operating revenue | 25.85%7.31B | 15.51%6.13B | 11.74%5.66B | 2.87%22.53B | 3.36%6.35B | 0.20%5.81B | 8.05%5.3B | 0.31%5.07B | 12.98%21.9B | 6.26%6.14B |
Cost of revenue | 9.27%4.76B | 5.33%4.29B | 2.36%4.06B | -5.34%17.09B | -4.17%4.69B | -8.12%4.35B | -2.25%4.08B | -6.62%3.97B | 17.66%18.05B | 4.48%4.89B |
Gross profit | 75.62%2.55B | 49.34%1.83B | 45.42%1.61B | 41.37%5.44B | 32.85%1.66B | 37.58%1.45B | 66.27%1.23B | 36.75%1.1B | -4.79%3.85B | 13.82%1.25B |
Operating expense | 2.20%2.61B | -3.47%2.42B | -2.20%2.42B | -13.94%10.51B | -17.11%2.96B | -11.90%2.56B | -14.48%2.51B | -11.42%2.48B | 16.57%12.21B | 15.48%3.58B |
Selling and administrative expenses | 14.51%1.71B | 4.51%1.52B | 0.48%1.46B | -18.86%6.04B | -21.39%1.64B | -15.84%1.49B | -18.90%1.46B | -18.85%1.45B | -2.50%7.44B | -9.43%2.08B |
-Selling and marketing expense | 21.17%1.2B | 12.79%1.04B | 5.33%927.06M | -20.42%3.92B | -11.11%1.13B | -19.24%992.3M | -21.65%918.2M | -29.80%880.19M | -15.08%4.92B | -28.13%1.27B |
-General and administrative expense | 1.25%505.39M | -9.57%488.04M | -6.98%531.78M | -15.81%2.12B | -37.33%511.91M | -8.14%499.13M | -13.74%539.7M | 6.80%571.7M | 37.20%2.52B | 51.79%816.81M |
Research and development costs | -15.01%906.07M | -14.57%894.7M | -6.00%965.12M | -6.25%4.47B | -11.15%1.33B | -5.73%1.07B | -7.46%1.05B | 1.77%1.03B | 67.80%4.77B | 87.28%1.49B |
Operating profit | 93.98%-66.68M | 54.20%-585.14M | 40.45%-818.6M | 39.41%-5.06B | 43.94%-1.3B | 40.12%-1.11B | 41.69%-1.28B | 30.95%-1.37B | -30.00%-8.36B | -16.39%-2.33B |
Net non-operating interest income expense | -16.20%73.46M | -22.60%80.54M | 14.75%101.63M | 1,153.14%377.55M | 117.37%97.27M | 368.16%87.66M | 2,097.50%104.05M | 414.80%88.57M | 135.40%30.13M | 290.30%44.75M |
Non-operating interest income | -22.46%91.28M | -34.00%100.34M | -8.93%133.21M | 93.02%542.47M | 16.75%126.45M | 42.73%117.72M | 171.63%152.03M | 326.45%146.27M | 299.41%281.05M | 307.43%108.31M |
Non-operating interest expense | -40.71%17.82M | -58.71%19.81M | -45.28%31.57M | -34.27%164.93M | -54.09%29.18M | -52.84%30.06M | -21.58%47.98M | -7.57%57.71M | 61.40%250.92M | 26.87%63.56M |
Other net income (expense) | 68.31%-95M | 68.71%-109.7M | -106.70%-46.11M | -105.02%-46.37M | -110.44%-84.15M | -312.31%-299.76M | -264.88%-350.64M | 392.31%688.18M | 563.83%924.31M | 2,118.43%805.88M |
Gain on sale of security | 71.41%-76.87M | 61.68%-109.96M | -128.46%-79.31M | 14.67%-471.22M | -90.04%-194.16M | -332.28%-268.83M | -529.64%-286.92M | 144.06%278.69M | -163.36%-552.23M | -14.44%-102.17M |
Special income (charges) | --0 | --0 | -106.24%-20.98M | -77.84%292.21M | --0 | --9.77M | -139.44%-54.04M | -0.68%336.49M | --1.32B | --842.8M |
-Less:Other special charges | ---- | --0 | 106.24%20.98M | 77.84%-292.21M | --0 | ---9.77M | 139.44%54.04M | 0.68%-336.49M | ---1.32B | ---842.8M |
Other non- operating income (expenses) | 55.44%-18.13M | 102.65%256K | -25.78%54.18M | -16.02%132.64M | 68.61%110.01M | -259.90%-40.7M | -209.02%-9.68M | 25.06%73.01M | 1,417.09%157.94M | 32.21%65.24M |
Income before tax | 93.31%-88.22M | 59.70%-614.3M | -27.62%-763.07M | 36.07%-4.73B | 12.53%-1.29B | 21.89%-1.32B | 23.16%-1.52B | 73.48%-597.91M | -10.28%-7.4B | 28.43%-1.48B |
Income tax | -146.84%-8.42M | -125.79%-6.15M | -95.08%1.56M | -24.43%78.71M | -74.88%5.14M | -33.63%17.98M | -11.12%23.86M | 6.63%31.73M | 9.29%104.15M | -37.59%20.46M |
Net income | 94.03%-79.81M | 60.72%-608.15M | -21.44%-764.63M | 35.91%-4.81B | 13.38%-1.3B | 22.07%-1.34B | 23.00%-1.55B | 72.43%-629.65M | -10.26%-7.51B | 28.57%-1.5B |
Net income continuous Operations | 94.03%-79.81M | 60.72%-608.15M | -21.44%-764.63M | 35.91%-4.81B | 13.38%-1.3B | 22.07%-1.34B | 23.00%-1.55B | 72.43%-629.65M | -10.26%-7.51B | 28.57%-1.5B |
Minority interest income | -102.04%-290K | 138.67%551K | -721.13%-16.09M | 199.70%10.61M | 91.35%-206K | 648.19%14.2M | 59.49%-1.43M | 8.88%-1.96M | 45.47%-10.64M | 69.28%-2.38M |
Net income attributable to the parent company | 94.12%-79.52M | 60.65%-608.7M | -19.25%-748.55M | 35.68%-4.82B | 13.26%-1.3B | 21.13%-1.35B | 22.93%-1.55B | 72.49%-627.69M | -10.43%-7.5B | 28.42%-1.49B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 94.12%-79.52M | 60.65%-608.7M | -19.25%-748.55M | 35.68%-4.82B | 13.26%-1.3B | 21.13%-1.35B | 22.93%-1.55B | 72.49%-627.69M | -10.43%-7.5B | 28.42%-1.49B |
Basic earnings per share | 94.17%-0.19 | 61.07%-1.46 | -17.65%-1.8 | 38.55%-11.67 | 16.98%-3.13 | 24.88%-3.26 | 26.18%-3.75 | 73.62%-1.53 | -6.27%-18.99 | 29.40%-3.77 |
Diluted earnings per share | 94.17%-0.19 | 61.07%-1.46 | -17.65%-1.8 | 38.55%-11.67 | 16.98%-3.13 | 24.88%-3.26 | 26.18%-3.75 | 73.62%-1.53 | -6.27%-18.99 | 29.40%-3.77 |
Dividend per share | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |